CMBN Cambian Group

TIDMCMBN

RNS Number : 3351I

Cambian Group PLC

29 May 2014

Cambian Group Plc

Appointment of Non-Executive Director

Cambian Group plc ("Cambian") is pleased to announce the appointment of Chris Brinsmead as Non-Executive Director and Chairman of the Remuneration Committee. He will also be the Senior Independent Director. Mr Brinsmead, 55, will join the Board on 1 July.

Mr Brinsmead has considerable experience in the life sciences sector. He has held numerous senior positions in his 20 year career at AstraZeneca, including CEO of Astra Zeneca UK and most recently Chairman of AstraZeneca UK, where he was responsible for developing relationships between AstraZeneca and the UK Government. Additionally, he was President of the Association of the British Pharmaceutical Industry.

Mr Brinsmead is a Non-Executive Director of Domino Printing Sciences PLC (a FTSE 250 company), UDG Healthcare plc and Chairman of the Remuneration Committee at the Wesleyan Assurance Society, as well as Chairman or Non-Executive Director of several private companies in the healthcare sector. He is also Life Sciences Business Advisor to the UK Government which involves working with the life sciences industry, the NHS and academia to provide independent advice to the Government on the sector.

An engineering graduate from Nottingham University, Mr Brinsmead has a M.Sc from Manchester University and a MBA from Manchester Business School.

Christopher Kemball, Non-Executive Chairman of Cambian, said:

"I am delighted to welcome Chris to the Group as Non-Executive Director, Chairman of the Remuneration Committee and SID. Cambian's vision is to be the highest quality provider of specialist behavioural health services to children and adults, and we have been shaping the expertise and capabilities of the Board accordingly. Chris's wealth of experience in the healthcare sector, as a non-executive director and in interactions with the UK Government and the NHS, will be a considerable asset to the Group. The Board, management team and I look forward to working with him."

There is no other information to disclose relating to Chris Brinsmead under Rule 9.6.13R of the Listing Rules in addition to the current and previous directorships listed above.

For more information contact:

Enquiries:

Cambian Group plc +44 (0) 20 8735 6150

Saleem Asaria, Chief Executive

Andrew Griffith, Chief Financial Officer

Tulchan Communications +44 (0) 20 7353 4200

Lucy Legh

Tom Buchanan

About Cambian Group plc:

The Cambian Group is one of the UK's largest specialist behavioural health service providers. Founded in 2004, it has grown to become a significant partner to the UK Government. The Group's services have a specific focus on children and adults who present high severity needs with challenging behaviours and complex care requirements. Cambian employs approximately 6,000 people across a UK-wide portfolio of 249 purpose-designed facilities, comprising 23 schools, 35 hospitals, 188 specialist homes and 3 fostering offices.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAQKCDKCBKKAPB

Grafico Azioni Cambian (LSE:CMBN)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Cambian (LSE:CMBN)
Storico
Da Lug 2023 a Lug 2024